Genetics
New approach for late-stage prostate cancer
(Medical Xpress)—For the past 70 years, androgen deprivation therapy (ADT) has been the standard treatment for men diagnosed with late-stage prostate cancer.
Jun 14, 2013
0
0
Page 11 - News tagged with androgen receptor
Oncology & Cancer
New direction for prostate cancer research a world first
Researchers at the University of Adelaide are spearheading a new direction in prostate cancer research, with the potential for new treatments of the disease.
Jun 3, 2013
0
0
Oncology & Cancer
Studies show increasing evidence that androgen drives breast cancer
Estrogen and progesterone receptors, and the gene HER2 – these are the big three markers and/or targets in breast cancer. Evidence presented at the AACR Annual Meeting 2013 adds a fourth: androgen receptors.
Apr 10, 2013
0
0
Oncology & Cancer
Counting copy numbers characterises prostate cancer
Non-invasive 'liquid biopsies' can find metastatic or recurrent prostate cancer, in a low cost assay suitable for most healthcare systems, finds research published in BioMed Central's open access journal Genome Medicine. ...
Apr 4, 2013
0
0
Oncology & Cancer
Mushroom-supplemented soybean extract shows therapeutic promise for advanced prostate cancer
A natural, nontoxic product called genistein-combined polysaccharide, or GCP, which is commercially available in health stores, could help lengthen the life expectancy of certain prostate cancer patients, UC Davis researchers ...
Feb 20, 2013
0
0
Oncology & Cancer
Researchers identify genetic root to early-onset prostate cancer
Prostate cancer is often considered an elderly man's disease, and little is known about the approximately 2% of cases that arise in men who are aged 50 years or younger. Research published in the February 11th issue of the ...
Feb 11, 2013
0
0
Oncology & Cancer
World-first tissue study could re-shape future of advanced prostate cancer treatment
The first-ever comprehensive study of prostate cancer tissue has revealed a completely new gene network driving the disease in patients who have stopped responding to standard hormone treatment, according to Cancer Research ...
Dec 21, 2012
0
0
Oncology & Cancer
Clinical trial hits new target in war on breast cancer
Breast cancers are defined by their drivers – estrogen and progesterone receptors (ER and PR) and HER2 are the most common, and there are drugs targeting each. When breast cancer has an unknown driver, it also has fewer ...
Dec 3, 2012
0
0
Oncology & Cancer
Noninvasive assay monitored treatment response in patients with metastatic prostate cancer
Deciding the ideal treatment for patients with metastatic prostate cancer that stops responding to initial therapy could be guided by certain analyses of cancer cells isolated from the patients' blood, according to data published ...
Oct 23, 2012
0
0
Neuroscience
Study sheds light on role of exercise and androgens such as testosterone on nerve damage repair
A study by researchers from Emory University and Indiana University found that the beneficial effects daily exercise can have on the regeneration of nerves also require androgens such as testosterone in both males and females. ...
Oct 15, 2012
0
0
